These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. Laiho M; Weis MB; Massagué J J Biol Chem; 1990 Oct; 265(30):18518-24. PubMed ID: 2170414 [TBL] [Abstract][Full Text] [Related]
7. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule. Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. Feng XH; Filvaroff EH; Derynck R J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630 [TBL] [Abstract][Full Text] [Related]
9. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723 [TBL] [Abstract][Full Text] [Related]
10. Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II. Laiho M; Weis FM; Boyd FT; Ignotz RA; Massagué J J Biol Chem; 1991 May; 266(14):9108-12. PubMed ID: 1851167 [TBL] [Abstract][Full Text] [Related]
12. Receptors for transforming growth factor-beta (TGF-beta) on rat lung fibroblasts have higher affinity for TGF-beta 1 than for TGF-beta 2. Kalter VG; Brody AR Am J Respir Cell Mol Biol; 1991 May; 4(5):397-407. PubMed ID: 1850605 [TBL] [Abstract][Full Text] [Related]
13. Differential binding of transforming growth factor-beta 1, -beta 2, and -beta 3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors. Lyons RM; Miller DA; Graycar JL; Moses HL; Derynck R Mol Endocrinol; 1991 Dec; 5(12):1887-96. PubMed ID: 1665203 [TBL] [Abstract][Full Text] [Related]
14. Characterization of distinct functional domains of transforming growth factor beta. Burmester JK; Qian SW; Roberts AB; Huang A; Amatayakul-Chantler S; Suardet L; Odartchenko N; Madri JA; Sporn MB Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8628-32. PubMed ID: 7690965 [TBL] [Abstract][Full Text] [Related]
15. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors. MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080 [TBL] [Abstract][Full Text] [Related]
16. Distinct functional domains of TGF-beta bind receptors on endothelial cells. Qian SW; Dumont N; O'Connor-McCourt MD; Burmester JK Growth Factors; 1999; 17(1):63-73. PubMed ID: 10495963 [TBL] [Abstract][Full Text] [Related]
17. Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein. Mitchell EJ; Lee K; O'Connor-McCourt MD Mol Biol Cell; 1992 Nov; 3(11):1295-307. PubMed ID: 1333844 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies. Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222 [TBL] [Abstract][Full Text] [Related]
19. Characterization of transforming growth factor-beta growth regulatory effects and receptors on bovine mammary cells. Woodward TL; Dumont N; O'Connor-McCourt M; Turner JD; Philip A J Cell Physiol; 1995 Nov; 165(2):339-48. PubMed ID: 7593212 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan. Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]